Richard W. Hill and Matthew J. Eddy both experienced healthcare regulatory attorneys at Lashly & Baer have written an article to assist health care providers.

With the establishment of the U.S. Department of Justice’s Prescription Interdiction & Litigation (PIL) Task Force,  it’s inevitable that physicians who dispense controlled substances will see an uptick in enforcement activity by the Drug Enforcement Agency (“DEA”) and Department of Justice (“DOJ”). Indeed, many clients have come to our firm reporting that a DEA or state controlled substance enforcement official appeared at their door, and asked to inspect their controlled substance records. Certain questions invariably follow, such as “Can the DEA do that?” and “What do I need to give the inspector?” This article attempts to answer some of these questions by focusing on the inspection process under the Controlled Substances Act (“CSA”). To read the full article CLICK HERE.

Share This